Meeting the challenge of rising API complexity: Lonza IP- and reaxys AI-enabled route design technology
first_published_at:Oct. 17, 2024, 2:47 p.m. / date_published:None
Newsfeeds
-
17/10/2024 -
The complexity of small molecule active pharmaceutical ingredients (APIs) is increasing, resulting in longer synthesis processes that pose challenges for innovators aiming for timely clinical readiness. Extended synthetic pathways complicate …
